Immunicum AB (publ) Announces Publication of Abstracts for the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium

    NEXT STORY
    Athenex CEO Informs Shareholders of Unrelated Matter Regarding Past Board Membership at Porton Pharma
    PREV STORY
    Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Arecor Announces Positive Headline Results for the First Phase I Clinical Trial of AT247, a Novel Ultra Rapid Acting Formulation of Insulin

    author_avatar
    NASDAQ Market News

    Athersys to Present at Jefferies 2019 Healthcare Conference

    author_avatar
    NASDAQ Market News

    Immune Design to Present at Upcoming Investor Conferences

    SEATTLE and SOUTH SAN FRANCISCO, Calif., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Immune Design ...

    author_avatar
    NASDAQ Market News